NCT05001282
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 1|Phase 2
Drug Category: Misc Inhibitor

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patient with active symptomatic central nervous system (CNS) metastases that is larger than 3 cm or requires treatment – see trial for details
https://ClinicalTrials.gov/show/NCT05001282